Treatment of female sexual dysfunction

Sexual dysfunction in human females can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms. Administration of apomorphine increases nerve stimulated clitoral intracavernosal blood flow and vaginal wall blood flow for enhanced clitor...

Full description

Saved in:
Bibliographic Details
Main Author P. E.-RASHIDY,B. RONSEN
Format Patent
LanguageEnglish
Published 12.04.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Sexual dysfunction in human females can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms. Administration of apomorphine increases nerve stimulated clitoral intracavernosal blood flow and vaginal wall blood flow for enhanced clitoral erection and vaginal engorgement in a female. A plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter is preferably maintained.
AbstractList Sexual dysfunction in human females can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms. Administration of apomorphine increases nerve stimulated clitoral intracavernosal blood flow and vaginal wall blood flow for enhanced clitoral erection and vaginal engorgement in a female. A plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter is preferably maintained.
Author P. E.-RASHIDY,B. RONSEN
Author_xml – fullname: P. E.-RASHIDY,B. RONSEN
BookMark eNrjYmDJy89L5WRQCylKTSzJTc0rUchPU0hLzU3MSVUoTq0oTcxRSKksTivNSy7JzM_jYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzn6GRqYGRkaGzs7GRCgBABs8KSg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN1250221CC
GroupedDBID EVB
ID FETCH-epo_espacenet_CN1250221CC3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:10:29 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN1250221CC3
Notes Application Number: CN19998004442
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060412&DB=EPODOC&CC=CN&NR=1250221C
ParticipantIDs epo_espacenet_CN1250221CC
PublicationCentury 2000
PublicationDate 20060412
PublicationDateYYYYMMDD 2006-04-12
PublicationDate_xml – month: 04
  year: 2006
  text: 20060412
  day: 12
PublicationDecade 2000
PublicationYear 2006
RelatedCompanies PENTECH PHARMACEUTICALS INC
RelatedCompanies_xml – name: PENTECH PHARMACEUTICALS INC
Score 2.6475842
Snippet Sexual dysfunction in human females can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Treatment of female sexual dysfunction
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060412&DB=EPODOC&locale=&CC=CN&NR=1250221C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNp-L8RR6kb8GVpGv7UISlLUOwG1Jlb6NpE_TBbdiK-N97iev0Rd9CApdL4O7LJXdfAK4Ld1DpkLtUce5TXsqCBp6vKVPK0H8PlCpttkU2HD_yu5k368BzWwtjeUI_LDkiWlSJ9t5Yf736ucSKbW5lfSNfsGt5m-ZR7GyiY0Mf5cSjKJlO4olwhIhE5mQPEeI4opUrtmAbD9G-Sf5KnkamJmX1G1DSA9iZoqxFcwgdtejBnmj_XevB7v36uRuba8urj8DJ24xwstREq1d07KS2fMmk-qwNPBmtj4GkSS7GFCecb9Y2F1mrmWAn0MWQX50CkSz0jHVURVHxMCgDHSqNLpL5krlyWPWh_6eYs3_GzmH_-wrBcBVeQLd5e1eXCKqNvLL78QUiJnw9
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFOebTsX5sw_St-JK07V9KMLSlqpbN6TK3krTJswHt2Er4n_vJa7TF30LCVwugbsvl9x9AbjOzX4pPGIanBDHIAXLDdd2hGFxLum_-5wXKtsiGcRP5H5mz1owb2phFE_ohyJHRIsq0N5r5a9XP5dYgcqtrG7YC3Ytb6PUD_RNdCzpo_Rg6IfTSTChOqU-TfTk0UccR7Qy6RZs4wHblSz74fNQ1qSsfgNKtA87U5S1qA-gxRdd6NDm37Uu7I7Xz93YXFtedQh62mSEa0uhCf6Kjl2rFF-yVn5WEp6k1kegRWFKYwMnzDZry2jSaEatY2hjyM9PQGOWZ0vrKPO8JJ5buMLjAl2k5TDLZIOyB70_xZz-M3YFnTgdj7LRXfJwBnvf1wmSt_Ac2vXbO79AgK3ZpdqbLx0efy0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Treatment+of+female+sexual+dysfunction&rft.inventor=P.+E.-RASHIDY%2CB.+RONSEN&rft.date=2006-04-12&rft.externalDBID=C&rft.externalDocID=CN1250221CC